{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:30:53Z","timestamp":1777984253586,"version":"3.51.4"},"reference-count":35,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As part of the framework of preparedness and response to influenza viruses with pandemic potential, the World Health Organization (WHO) has developed a protocol for the characterization of a series of first cases and contacts of an agent with pandemic potential (FFX). At the end of 2019, PAHO\/WHO invited Colombia to be among the pilot countries for implementing this protocol. It was conducted by the National Institute of Health of Colombia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The WHO generic protocol was reviewed and adapted to Colombia. In its implementation, a series of 99 cases of COVID\u201019 and 360 total contacts (159 positive contacts) were evaluated between August 2020 and January 2021 in three municipalities of Colombia. Surveys were conducted, along with RT\u2010PCR and antibody titer tests. Sociodemographic, clinical, and virological transmission conditions were analyzed to calculate the main epidemiological indicators of viral transmission using measures of central tendency and absolute and relative frequencies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 258 cases were confirmed to be positive for COVID\u201019 for a secondary attack rate of 43%. The most common symptoms were cough, fever, headache, and odynophagia. The percentage of symptomatic contacts, clinical attack rate, incubation period, and serial interval were 34%, 16.2%, 4.6\u2009days, and 4.7\u2009days, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The significant rate of infection and incubation periods among contacts was similar to those reported worldwide. The implementation of the WHO FFX protocol in a novel context allowed the country to test its capacity to implement global studies to determine early public health interventions. The study faced limitations due to the selection bias towards severe cases and challenges in case recruitment and contact tracing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/irv.70132","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:33:05Z","timestamp":1775626385000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating COVID\u201019 Transmission in a Series of Cases and Contacts in Three Municipalities of Colombia: Insights From the WHO First Few X Protocol, August 2020\u2013January 2021"],"prefix":"10.1111","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9941-4761","authenticated-orcid":false,"given":"Damaris","family":"Heredia","sequence":"first","affiliation":[{"name":"FETP Field Epidemiology Training Program, Public Health Human Talent Training Group National Institute of Health  Bogot\u00e1 Colombia"},{"name":"Directorate of Surveillance and Public Health Risk Analysis National Institute of Health  Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May\u00a0Bibiana","family":"Osorio","sequence":"additional","affiliation":[{"name":"FETP Field Epidemiology Training Program, Public Health Human Talent Training Group National Institute of Health  Bogot\u00e1 Colombia"},{"name":"Directorate of Surveillance and Public Health Risk Analysis National Institute of Health  Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Figueroa","sequence":"additional","affiliation":[{"name":"FETP Field Epidemiology Training Program, Public Health Human Talent Training Group National Institute of Health  Bogot\u00e1 Colombia"},{"name":"Directorate of Surveillance and Public Health Risk Analysis National Institute of Health  Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Ardila","sequence":"additional","affiliation":[{"name":"FETP Field Epidemiology Training Program, Public Health Human Talent Training Group National Institute of Health  Bogot\u00e1 Colombia"},{"name":"Directorate of Surveillance and Public Health Risk Analysis National Institute of Health  Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayner","family":"Vacca","sequence":"additional","affiliation":[{"name":"FETP Field Epidemiology Training Program, Public Health Human Talent Training Group National Institute of Health  Bogot\u00e1 Colombia"},{"name":"Directorate of Surveillance and Public Health Risk Analysis National Institute of Health  Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Santos","sequence":"additional","affiliation":[{"name":"Public Health Surveillance Group, Directorate of Public Health Secretariat of Health of Tolima  Ibagu\u00e9 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Velandia","sequence":"additional","affiliation":[{"name":"Directorate of Public Health Research National Institute of Health  Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Mercado","sequence":"additional","affiliation":[{"name":"Directorate of Public Health Research National Institute of Health  Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maritza","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"FETP Field Epidemiology Training Program, Public Health Human Talent Training Group National Institute of Health  Bogot\u00e1 Colombia"},{"name":"Directorate of Surveillance and Public Health Risk Analysis National Institute of Health  Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franklyn","family":"Prieto","sequence":"additional","affiliation":[{"name":"Directorate of Surveillance and Public Health Risk Analysis National Institute of Health  Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Garcia","sequence":"additional","affiliation":[{"name":"Pan American Health Organization, World Health Organization  Washington USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0061-7567","authenticated-orcid":false,"given":"\u00c1ngel","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Pan American Health Organization, World Health Organization  Washington USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"World Health Organization WHO \u201cGlobal Influenza Strategy 2019\u20132030 \u201d (2019) accessed on October 19 2022 https:\/\/www.paho.org\/es\/documentos\/estrategia\u2010mundial\u2010contra\u2010gripe\u20102019\u20102030."},{"key":"e_1_2_10_3_1","unstructured":"World Health Organization WHO \u201cThe First Few X Cases and Contacts (FFX) Investigation Protocol for Coronavirus Disease 2019 (COVID 19) \u201d Version 2. February 2020 accessed on July 25 2020 https:\/\/www.who.int\/docs\/default\u2010source\/coronaviruse\/covid\u201019\u2010master\u2010ffx\u2010protocol\u2010v2\u2010sp\u2010web.pdf."},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12915"},{"key":"e_1_2_10_5_1","first-page":"1","article-title":"The Ongoing Value of First Few X Studies for COVID\u201019 in the Western Pacific Region","volume":"13","author":"Marcato A. J.","year":"2022","journal-title":"Western Pacific Surveillance and Response Journal"},{"key":"e_1_2_10_6_1","unstructured":"National Institute of Health of Colombia \u201cInstructions for Intensified Public Health Surveillance of Acute Respiratory Infection and the Disease Associated With the New Coronavirus 2019 (COVID 19) Versi\u00f3n 13 of 2020 \u201d accessed January 7 2021 https:\/\/www.saludcapital.gov.co\/CTDLab\/Publicaciones\/2021\/Vigilancia_intensificada_COVID\u201019.pdf."},{"key":"e_1_2_10_7_1","unstructured":"CDC \u201cRealtime RT\u2010PCR Protocol for Detection and Characterization of Influenza \u201d (2009) Centers for Disease Control and Prevention Atlanta EEUU accessed June 30 2021 https:\/\/www.who.int\/csr\/resources\/publications\/swineflu\/CDCRealtimeRTPCR_SwineH1Assay\u20102009_20090430.pdf."},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560\u20107917.ES.2020.25.3.2000045"},{"key":"e_1_2_10_9_1","unstructured":"M. M.Reyes V. V.Rubio andD. A.Velandia\u2010Rodr\u00edguez \u201cSecondary Validation and Verification of the Performance of the Serological Test for the in Vitro Diagnosis of IgG Antibodies Against SARS\u2010CoV\u20102 (ELISA) \u201cID.VET SARS\u2010CoV\u20102 N IgG Indirect\u201d of \u201cInnovative Diagnostics\u201d Francia \u201d National Institute of Health \u2013 Colombia. 2020 (2020) accessed September 22 2022 https:\/\/www.ins.gov.co\/BibliotecaDigital\/Validacion\u2010secundaria\u2010prueba\u2010anticuerpos\u2010IDVET\u2010SARS\u2010CoV\u20102\u2010N\u2010IgG\u2010indirect\u2010Innovative\u2010Diagnostics.pdf."},{"key":"e_1_2_10_10_1","unstructured":"R. M.Mercado et\u00a0al. \u201cSecondary Validation and Verification of the Performance of the Serological Test for the in Vitro Diagnosis of Total Antibodies Against SARS\u2010CoV\u20102 (ELISA) \"WANTAI SARS\u2010CoV\u20102 AB ELISA Manufactured by Beijing Wantai Biological Pharmacy Enterprise Co. LTD. National Institute of Health \u2013 Colombia. 2020 \u201d (2020) accessed September 22 2022 https:\/\/www.ins.gov.co\/BibliotecaDigital\/Validacion\u2010prueba\u2010serologica\u2010in\u2010vitro\u2010contra\u2010SARS\u2010CoV\u20102\u2010AB\u2010ELISA\u2010WANTAI.pdf."},{"key":"e_1_2_10_11_1","unstructured":"D. A.Velandia\u2010Rodriguez \u201cThe High Viral Concentration of SARS\u2010CoV\u20102 Detected in Respiratory Secretion Samples From Patients With COVID\u201019 Could Be Responsible for the High Dissemination of the Virus in Bogot\u00e1 Colombia \u201d XII Meeting of Research in Infectious Diseases (2020) Infectio 24(3) supplement 3. P 57"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13002"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6942a5"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.20.265603"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.08.033"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa450"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233588"},{"key":"e_1_2_10_19_1","doi-asserted-by":"crossref","unstructured":"H.Nishiura H.Oshitani T.Kobayashi et\u00a0al. \u201cClosed Environments Facilitate Secondary Transmission of Coronavirus Disease 2019 (COVID\u201019) \u201d medRxiv (2020) https:\/\/doi.org\/10.1101\/2020.02.28.20029272.","DOI":"10.1101\/2020.02.28.20029272"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15889.2"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(20)30183\u20105"},{"key":"e_1_2_10_23_1","doi-asserted-by":"crossref","unstructured":"S.Ma J.Zhang M.Zeng et\u00a0al. \u201cEpidemiological Parameters of Coronavirus Disease 2019: A Pooled Analysis of Publicly Reported Individual Data of 1155 Cases From Seven Countries \u201d medrxiv (2020) https:\/\/doi.org\/10.1101\/2020.03.21.20040329.","DOI":"10.1101\/2020.03.21.20040329"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311x00238720"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.JJID.2020.943"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2021.38.217.27859"},{"key":"e_1_2_10_27_1","unstructured":"Ministry of Health Government of Spain. Health Alerts and Emergencies Coordination Center \u201cScientific \u2010 Technical Information. Coronavirus Disease. 2019 \u201d accessed September 01 2021 https:\/\/pnsd.sanidad.gob.es\/noticiasEventos\/actualidad\/2020_Coronavirus\/pdf\/20200421_INFORME_CIENTIFICO_SANIDAD_COVID\u201019.pdf."},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013652.pub2"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2020.12.020"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.36104\/amc.2019.1293"},{"key":"e_1_2_10_31_1","unstructured":"National Administrative Department of Statistics of Colombia (DANE) \u201cVital Statistics \u2010EEVV \u201d accessed July 29 2021 https:\/\/www.dane.gov.co\/files\/investigaciones\/poblacion\/pre_estadisticasvitales_Itrim_2020pr.pdf."},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2021.04.021"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rce.2020.08.005"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879\u2010021\u201006166\u20109"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semerg.2020.06.001"},{"key":"e_1_2_10_36_1","unstructured":"Pan American Health Organization (PAHO) \u201cInfluenza SARS\u2010CoV\u20102 RSV and Other Respiratory Viruses [Internet] \u201d Washington D.C.: PAHO; [Updated 2023; accessed March 21 2025] https:\/\/www.paho.org\/es\/temas\/influenza\u2010sars\u2010cov\u20102\u2010vsr\u2010otros\u2010virus\u2010respiratorios."}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70132","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/irv.70132","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:53:47Z","timestamp":1777276427000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.70132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1111\/irv.70132"],"URL":"https:\/\/doi.org\/10.1111\/irv.70132","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/IRV.70132\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70132\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70132\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70132\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70132\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70132\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70132\/v1\/decision1","asserted-by":"object"}]},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2024-05-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70132"}}